Special reports Archives - Parkinson's Life

Special reports

Mike Isles shares his top tips on how to stay safe
READ MORE
Special reports

Dr Kieran Breen on the supply and manufacture of medication
READ MORE
Special reports

Two thirds of Parkinson’s patients do not get their medication on time
READ MORE

Special reports

Ask the expert: How to spot fake Parkinson’s medicines online

Mike Isles shares his top tips on how to stay safe

READ MORE

Special reports

Ask the expert: How will Brexit affect Parkinson’s drugs and research?

Dr Kieran Breen on the supply and manufacture of medication

READ MORE

Parkinson's hospitals

Special reports

Are UK hospitals safe for people with Parkinson’s?

Two thirds of Parkinson’s patients do not get their medication on time

READ MORE

Special reports

Parkinson’s and depression: it’s not all in your mind

Depression may be common among PwPs, but it's not a sign of weakness

READ MORE

Scientists working in a lab

Special reports

Prostate drug could “change the lives of people with Parkinson’s”

The drug could slow down and stop Parkinson’s progression

READ MORE

sex and Parkinson's

Special reports

Regular sex improves Parkinson’s symptoms for men, study finds

Regular sex can lessen effects of Parkinson’s in men

READ MORE

Testing on animals

Special reports

Parkinson’s and animal testing: the case against

In the second in our series, we explore the debate

READ MORE

animal testing

Special reports

Do we have the right to test Parkinson’s medications on animals?

We explore the debate surrounding Parkinson’s and animal testing

READ MORE

fitness

Special reports

Age, smoking and lack of fitness increase risk of Parkinson’s

More than 7300 male veterans took part in the study

READ MORE

compulsive behaviour

Special reports

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

READ MORE

Head injury

Special reports

A single head injury could increase risk of Parkinson’s

A study has found a link between head injuries and Parkinson’s

READ MORE

woman talking with business colleagues in office

sponsored article

Special reports

STEP – The lived experience of Parkinson’s disease

STEP™ hopes to give a voice to people living with Parkinson’s

READ MORE

Crowded sidewalk on Oxford Street in London

Special reports

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

READ MORE

Parkinson's pandemic lead

Special reports

Neurological disorders – including Parkinson’s – are leading source of disability globally

Parkinson’s is world’s fastest growing neurological disorder

READ MORE

Worried couple reading a letter

Special reports

£16,000 a year: the hidden price of Parkinson’s

Research reveals the monetary cost of Parkinson’s for UK families

READ MORE

Special reports

Muhammad Ali’s death “has raised Parkinson’s awareness”

Muhammad Ali’s legacy lives on

READ MORE

Bloem, Okun, Lindvall

Special reports

How close are we to a Parkinson’s breakthrough? Three experts have their say

Renowned experts give their opinions on the next breakthrough

READ MORE

umotif-100-for-parkinsons-app-lead

Special reports

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Latest findings from 100 for Parkinson’s study released

READ MORE

Sniffer dogs lead

Special reports

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

Dogs have been trained to sniff out Parkinson’s disease

READ MORE

100 For Parkinson's lead

Special reports

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

“We cannot gather too much data”

READ MORE

PD UK survey

Special reports

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Parkinson’s patients “too afraid” to reveal diagnosis

READ MORE

Pyhsiotherapy APPDE

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

READ MORE

Special reports

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Second Life: a (virtual) world without Parkinson’s

READ MORE

Special reports

Are we too focused on the search for a Parkinson’s cure?

We ask Parkinson’s experts for their views on this controversial debate

READ MORE

Special reports

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Shedding light on the dementia often mistaken for Parkinson’s

READ MORE

Special reports

“Brain Surgery Live is a modern medical miracle the public deserved to see”

Exposure for such modern miracles is crucial, argues Justin Rossi

READ MORE

Special reports

The future generation of advanced therapies for Parkinson’s

Dr Kieran Breen explores the potential of stem cell & gene therapies

READ MORE

Special reports

Neurologists should be ‘guides not gods’ – Part 2

Top expert Bastiaan Bloem argues the case for a more holistic approach

READ MORE

Special reports

Neurologists should be ‘guides not gods’ – Part 1

Why physicians need to come down from their 'ivory towers'

READ MORE

4 weeks ago

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”

Read more

1 month ago

Could playing table tennis help reduce Parkinson’s symptoms?

Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…

Read more

1 month ago

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Read more

Subscribe

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Terms and Privacy Policy